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Introduction
The use of xenogeneic organs could solve the severe shortage of organs for transplantation (1, 2) . The pig is considered a promising candidate as a potential source animal (1, 2) . Despite the progress in recent years (3) (4) (5) (6) , robust immunological rejection remains a major obstacle to xenotransplantation (7) . An attractive approach to preventing xenograft rejection is tolerance induction so that the human immune system is specifically unresponsive to the pig xenografts (1, 2, 8) , thus avoiding the use of long-term immunosuppression while preserving the ability of the immune system to respond to pathogens.
Mixed chimerism is a state in which host and donor hematopoietic cells coexist (9) . The achievement of sustained mixed xenogeneic chimerism by hematopoietic cell transplantation has been shown to prevent xenograft rejection in mouse models (10) . Mixed xenogeneic chimerism in the rat-to-mouse and pig-to-mouse models leads to the tolerization of T cells, and in rat-to-mouse chimeras, of B cells, which are the major cell types mediating xenograft rejection (11) (12) (13) (14) (15) . Natural killer (NK) cells have been implicated in xenograft rejection in rodents (16, 17) and primates (18, 19) . We have previously shown in a mixed allogeneic chimerism model that specific tolerance of host NK cells could be induced (20) . In a rat-to-mouse xenogeneic transplantation model, we demonstrated that mixed xenogeneic chimerism induced global unresponsiveness of recipient NK cells, because they were unable to reject either donor rat or b2m (class I major histocompatibility complex [MHC] )-deficient mouse bone marrow cells (BMCs) (21) . Currently, it is unclear whether mixed chimerism can induce human NK cell tolerance to pig xenografts.
In this study we address this question using a humanized mouse model where pig and human mixed hematopoietic chimerism is induced (22) . Our results show that induction of human NK cell development in pig/human mixed chimeras does not affect pig chimerism. Human NK cells from the majority of pig/human mixed chimeric mice show a trend of either specific loss of cytotoxicity to pig cells or global hyporesponsiveness. These data indicate that mixed xenogeneic hematopoietic chimerism can downregulate responses of human NK cells to pig cells.
Materials and Methods

Animals and tissues
NSG (NOD.Cg-Prkdc
scid Il2rg tm1Wjl ) and porcine cytokine-transgenic NSG mice (PCT-NSG, expressing pig IL-3, granulocyte-macrophage colonystimulating factor [GM-CSF] and stem cell factor) purchased from Jackson Laboratory (Bar Harbor, ME) were housed and bred in a specific pathogen-free environment. Human fetal liver tissues (gestational age, 17-23 weeks) were obtained from Advanced Bioscience Resource (Alameda, CA). Swine BMCs were harvested from adult swine leukocyte antigen (SLA)-defined miniature swine (provided by Dr. David H. Sachs, Massachusetts General Hospital). Studies were approved by the Institutional Review Board and Institutional Animal Care and Use Committee at Columbia University.
Human fetal and porcine tissue transplantation
NSG or PCT-NSG mice (6-10 weeks old) were sublethally irradiated (1-1.2 Gy) by an X-ray irradiator (RS-2000, Rad Source Technologies, Suwanee, GA). To generate pig/human mixed chimeric mice, fresh or cryopreserved pig BMCs(1 9 10 8 /mouse, SLA-DD) were injected into irradiated PCT-NSG mice followed by injection of fresh or cryopreserved fetal liver-derived human CD34 + cells (1-2 9 10 5 /mouse) through the tail vein 3 days later. To generate nonchimeric humanized mice, CD34 + human fetal liver cells (1-2 9 10 5 ) were injected alone.
Flow cytometry
Levels of pig and human hematopoietic chimerism in transplanted mice were assessed by multicolor flow cytometry (FCM) as described (23) . Mice were tail bled at regular intervals after transplantation. Fluorochrome-labeled monoclonal antibodies were purchased from Biolegend (San Diego, CA) or BD Pharmingen (San Jose, CA) or were obtained from Massachusetts General Hospital. FCM analysis was performed using a FACSCantoII or LSRII (BD Pharmingen), and data were analyzed by FlowJo software (TreeStar, Ashland, OR). Humanized mice were defined as chimeric when ≥0.003% pan-pig-positive cells were found within peripheral blood white blood cells or white blood cells in organs (Figure S1 ). Human NK cells from humanized mice were defined as human CD45
Induction of human NK cell reconstitution
Human NK cell reconstitution was induced 14 weeks following injection of fetal liver CD34 + cells, when porcine and human reconstitution were complete. Humanized mice first received hydrodynamic injection of plasmid encoding human Flt3L (50 lg/mouse, Day 0) followed by injection of recombinant human IL-15 (rhIL-15) (Gemini Bio-Products, West Sacramento, CA)/recombinant human IL-15 receptor alpha Fc chimeric protein (rhIL-15Ralpha-Fc) (R&D Systems, Minneapolis, MN) complex 3, 7, 11, and 13 days later. To generate the complex, rhIL-15 and rhIL-15Ralpha-Fc were incubated at a ratio by weight of 1:2 in 100 lL of phosphate buffered saline (PBS) at 37°C for 30 min (24) . Mice were injected intravenously with rhIL-15/rhIL-15Ralpha-Fc complex (0.5 lg rhIL-15 and 1 lg rhIL-15Ralpha-Fc/mouse/injection). For simplicity, this complex is referred to as "IL-15" throughout this paper. Plasmid encoding human Flt3L was a gift from Dr. Jianzhu Chen (MIT, Cambridge, MA) and was prepared as described (25) .
Human NK cell purification
Humanized mouse splenocytes were prepared and human NK cells were enriched using antihuman CD56 microbeads (Miltenyi Biotec, Auburn, CA). NK cells were enriched from human peripheral blood mononuclear cells (PBMCs) by depletion of human T cells using antihuman CD3-biotin antibody and antibiotin microbeads followed by positive selection with antihuman CD56 microbeads. Purity of NK cells ranged from 70% to 90%.
In vitro NK cytotoxicity assay
In initial experiments, cytotoxicity of NK cells was determined by the standard chromium ( 51 Cr) release assay as described (21) . Briefly, splenic NK cells isolated from chimeric and nonchimeric humanized mice in triplicate were serially diluted and coincubated with various 51 Cr-labeled target cells for 4 h. Because flat or irregular titrations were often observed with chromium release assays of NK activity in our hands, we adapted a radioisotope-free method of measuring NK cell cytotoxicity that has previously been used in T cell cytotoxicity assays (26) . NK cell targets, including pig lymphoblasts, K562 cells and nonobese diabetic (NOD) mouse lymphoblasts, were stained with 5 lM carboxyfluorescein succinimidyl ester (CFSE) (see Supplemental Methods for details of generation of lymphoblasts). Human B cells, isolated from humanized mouse splenocytes or human peripheral blood, were stained with 0.5 lM CFSE and used as an internal control population. CFSE-labeled human B cells (CFSE low )
were then mixed with NK cell targets (CFSE high ) at a ratio of 1:1, and Figure S2 for further details). Percentage of specific killing was calculated using the following formula, as described (26):
Cytotoxicity ¼ 100% Â 1 À ðB cells=NK cell targetsÞ without effector ðB cells=NK cell targetsÞ with effector Cytotoxicity was defined as measurable if the percentage of specific killing was >10%.
The ratio of the maximum killing of pig lymphoblasts to that of K562 cells by NK cells from the same mouse was used to represent the response status of the human NK cells. The ratios from nonchimeric and chimeric mice were compared. However, if the maximum killing of K562 cells by NK cells of the chimeric mouse was less than half that of the maximum killing of K562 cells by NK cells of the nonchimeric mouse, NK cells were considered globally hyporesponsive, and the mice with this characteristic were excluded from the comparison described above, because there were no instances of killing of pig lymphoblasts by NK cells that were hyporesponsive to K562 cells.
IFN-c detection
Humanized mouse splenocytes or human PBMCs were stimulated with phorbol myristate acetate (PMA) (50 ng/mL) and Ionomycin (500 ng/mL) (Sigma, St. Louis, MO) for 5 h in the presence of Brefeldin A (Biolegend). Intracellular staining was then performed to detect human NK cell interferon gamma (IFN-c) production. In some studies, human NK cells from human peripheral blood and humanized mouse spleen and bone marrow (BM) were cocultured with pig lymphoblasts or K562 cells at a ratio of 1:1 for 4 h, and human NK cell IFN-c production was determined using an IFN-c capture assay kit (Miltenyi Biotec).
Statistical analysis
Statistical analyses were performed using GraphPad Prism software (La Jolla, CA). Student's t-test (two-tailed) or ANOVA was used for analyses. A p-value of <0.05 was considered to be statistically significant. Data are presented as mean AE SEM (standard error on the mean).
Results
Enhancing human NK cell reconstitution in humanized mice Owing to the absence of human IL-15 and the inability of human cells to respond to mouse IL-15 (27) , reconstitution of human NK cells in humanized mice is very low (24, 27 Figure 2A ). PMA/Ionomycininduced production of IFN-c by human NK cells from spleen of humanized mice was comparable to that produced by NK cells from human peripheral blood (Figure 2B ). Enriched human NK cells from the spleen of humanized mice were able to kill both K562 cells and pig lymphoblasts, whereas the killing of NOD lymphoblasts was very low ( Figure 2C ). These data demonstrated that NK cells reconstituted in humanized mice were functionally intact and were able to kill xenogeneic pig cells, even though they had developed in the mouse xenogeneic environment. Furthermore, the human NK cells were unresponsive to the host, suggesting that they were either tolerant or unable to interact with mouse cells. The failure of normal human peripheral blood NK cells to kill NOD mouse lymphoblasts ( Figure 2C ) is consistent with the latter possibility. Collectively, these data demonstrated that our humanized mouse model was suitable for investigation of the impact of mixed xenogeneic chimerism on the tolerance of human NK cells to pig cells.
Human NK cell reconstitution has no impact on pig/ human mixed chimerism We next investigated the impact of mixed xenogeneic hematopoietic chimerism on NK cell function and xenoresponsiveness. We reasoned that if human NK cells developing in the presence of pig/human mixed chimerism were tolerant to pig cells, inducing human NK cell + cells, hydrodynamic injection of plasmid encoding human Flt3L (50 lg/ mouse) was performed (Day 0) followed by intravenous injection of human IL-15 on Days 3, 7, 11 and 13. On Day 14, humanized mice were euthanized and NK cells were purified from the spleens using antihuman CD56 microbeads. Control NK cells were enriched from human PBMCs by depletion of human T cells using antihuman CD3-biotin antibody and antibiotin microbeads followed by positive selection with antihuman CD56 microbeads. Purified human NK cells were then further used to evaluate cytotoxicity against pig lymphoblasts and K562 cells. Human NK cells and pig cells in various lymphoid tissues were analyzed by flow cytometry. For studies described in Figure 2 , nonchimeric mice generated with injection of only human fetal liver-derived CD34 + cells were used. BMCs, bone marrow cells; NK, natural killer. reconstitution would not lead to a decrease in pig chimerism compared with that in pig/human mixed chimeric mice without induction of human NK cell reconstitution. To this end, we compared the pig chimerism in pig/ human mixed chimeric humanized mice receiving and not receiving Flt3L and IL-15.
As shown in Figure 3 (A), no significant differences in kinetics of pig peripheral blood chimerism were found between chimeric mice receiving Flt3L and IL-15 and control groups, although the numbers of pig cells in peripheral blood in all groups showed a gradual decrease over time. Similar numbers of pig cells were found in spleen, BM and liver among chimeric mice receiving or not receiving Flt3L and IL-15 ( Figure 3B ). Treatment with Flt3L and IL-15 had no direct effect on pig chimerism in mice that did not have a human immune system (Figure S3 ). Although consistent with the possibility that human NK cells developing in the presence of mixed xenogeneic chimerism were hyporesponsive to pig cells, Figure 2 : Provision of exogenous human Flt3L and IL-15 enhances human NK cell reconstitution in humanized mice. Humanized mice were generated by injection of human fetal liver-derived CD34 + cells to irradiated NSG mice. Fourteen weeks later, when mice were fully reconstituted by human cells, plasmid encoding human Flt3L was administered by hydrodynamic injection to these mice followed by injection of human IL-15. (A) Humanized mice without treatment (n = 3) or treated with PBS (n = 4) were used as controls for humanized mice treated with human Flt3L and IL-15 (n = 4). Human NK cells in tissues were quantified. BM, bone marrow; PB, peripheral blood. Error bars represent SEM. *p < 0.05 with ANOVA, compared with PBS-treated group. (B) Splenocytes from humanized mice treated with human Flt3L and IL-15 were stimulated with PMA/Ionomycin for 5 h in the presence of Brefeldin A followed by intracellular staining to determine the production of IFN-c by human NK cells. Error bars represent SEM. *p < 0.05 with a Student's t-test. NK cells from human PBMCs served as a control and were not included in the statistical analysis. (C) Human splenic NK cells from the spleen of humanized mice were isolated and their cytotoxic responses to pig lymphoblasts, K562 cells and NOD mouse lymphoblasts were determined. Effector:target (E:T) ratio is shown on the x-axis. NK cells from human PBMCs served as a control. BM, bone marrow; IFN-c, interferon gamma; NK, natural killer; NOD, nonobese diabetic; PB, peripheral blood; PBS, phosphate buffered saline; PBMC, peripheral blood mononuclear cell; PMA, phorbol myristate acetate; SP, spleen. these data were inconclusive because of the loss of pig chimerism in control animals. Notably, mice receiving pig BMCs alone had higher numbers of porcine cells in BM and spleen than mixed chimeric mice ( Figure 3B ), regardless of Flt3L and IL-15 treatment, indicating that human populations other than NK cells might destroy or outcompete pig hematopoietic cells in these tissues.
Mixed xenogeneic chimerism can lead to specific human NK cell unresponsiveness to pig cells or global hyporesponsiveness in vitro We performed cytotoxicity assays to further determine the responses of human NK cells in pig/human mixed chimeric mice to pig cells (Figure 1 ). We tested human NK cells from a total of 13 mixed chimeric mice in 4 separate experiments, including the experiment presented in Figure 3 . Treatment of chimeric and nonchimeric mice with human Flt3L and IL-15 led to increased percentages of human T cells and decreased percentages of human B cells in peripheral blood ( Figure S4 ). NK cells from 3 of these mice showed markedly lower cytotoxicity to both pig cells and K562 cells than did NK cells from nonchimeric mice. Because this pattern was not seen in any of 8 nonchimeric mice, these data suggest that the presence of porcine chimerism rendered human NK cells globally hyporesponsive ( Figure 4B and Table S1 ). For the other 10 chimeric mice, cytotoxicity against K562 cells was ≥50% of that of nonchimeric controls, and we compared the ratios of maximum killing of pig cells versus K562 cells to those of nonchimeric mice. Ratios for the chimeric mice were significantly lower than those for the nonchimeric humanized mice, demonstrating that mixed xenogeneic chimerism led to specific hyporesponsiveness of human NK cells to pig cells (Figures 4A and B) . However, some chimeric mice showed similar killing of pig lymphoblasts and K562 cells, and some showed only reduced responsiveness to the pig ( Figure 4A ), suggesting that incomplete tolerance was induced by porcine chimerism. We routinely determined the pig/human mixed chimerism in all tissues when human NK cells were isolated and tested for cytotoxicity ( Figure S1 ). We did not detect any significant difference in cytotoxicity between mice with or without measurable porcine chimerism in the spleen ( Figure S5 ). These data indicated that hyporesponsiveness of human splenic NK cells did not require the persistent presence of measurable pig chimerism in the spleen. No significant differences in NK and pig cell levels in tissues were found between the 3 chimeric mice showing global hyporesponsiveness and the 10 chimeric mice showing specific hyporesponsiveness. However, mice showing global hyporesponsiveness had altered NK cell phenotypes in their tissues ( Figure S6 ).
Comparison of cytokine responses of human NK cells from chimeric and nonchimeric mice with pig lymphoblasts and K562 cells showed that a significant percentage of human peripheral blood NK cells expressed IFN-c when stimulated with pig lymphoblasts or K562 cells ( Figure 5 ). However, the percentages of IFN-c + human NK cells from the spleen and BM of both chimeric and nonchimeric mice in response to pig lymphoblast and K562 cell stimulation were much lower than those of normal human peripheral blood NK cells, suggesting that the cytokine production function of human NK cells in humanized mice was suboptimal. No difference was detected between chimeric and nonchimeric mice in IFN-c production by human splenic and BM NK cells in response to pig lymphoblast stimulation. Although no difference was detected between chimeric and nonchimeric mice in IFN-c production by splenic NK cells stimulated with K562 cells, percentages of IFN-c + BM NK cells in chimeric mice were significantly lower than those in nonchimeric mice (p < 0.05; Figure 5B ), suggesting that global hyporesponsiveness was induced in BM NK cells of mixed chimeras.
Phenotypic characterization of NK cells in mixed chimeras
We compared the immunophenotype of human NK cells from mixed chimeric and nonchimeric humanized mice from various tissues ( Figure 6 ). Human NK cells of the spleen and peripheral blood showed a more mature phenotype than those in BM or liver, with greater killer cell immunoglobulin-like receptor (KIR) expression. In general, no differences were found in the expression of these markers in NK cells from the two groups of mice. Expression by human NK cells from chimeric mice of significant levels of CD94, NKG2D, NKp30, NKp46 and KIR suggests that hyporesponsiveness to pig cells induced by mixed xenogeneic chimerism was not associated with an immature phenotype. Activation markers, such as CD25 and CD69, were not expressed, suggesting that human NK cells were not activated by pig cells in vivo in mixed chimeras. However, in BM a significantly higher percentage of CD56 bright CD16 dim and a lower percentage of CD56 dim CD16
bright human NK cell subsets were detected in chimeric compared with nonchimeric mice (Figure 6 ). No significant difference in the CD56 dim CD16 dim NK subset was found between the chimeric and nonchimeric mice. However, the percentages of this population in BM NK cells seemed to be higher than that recently reported for normal human BM (28) . Although there were no differences in any NK cell subsets in the peripheral blood of chimeric versus nonchimeric mice, percentages of CD56 dim CD16
high and CD56 dim CD16 dim NK cells in human peripheral blood were significantly higher and lower, respectively, than those in the peripheral blood of both chimeric and nonchimeric mice.
Discussion
The relatively long-lasting pig/human mixed chimerism in our humanized mouse model permits analysis of the impact of this chimerism on human NK cell function. Global hyporesponsiveness of human NK cells in the presence of abundant murine recipient cells might have been predicted in humanized mice on the basis of our previous findings in the rat-to-mouse model, in which host mouse NK cells were rendered globally unresponsive by low levels of rat mixed chimerism (21) . However, resting human peripheral blood NK cells show negligible cytotoxicity against NOD mouse lymphoblasts while demonstrating significant killing of pig lymphoblasts, suggesting a fundamental inability of human NK cells to interact with murine targets. Interactions between resting human NK cells and target cells leading to activation and killing involve multiple surface molecules such as LFA-1 and ICAM-1 interactions (29) . Although LFA-1 on human NK cells is able to bind to mouse ICAM-1 (30, 31) , this has been shown to lead to cytolytic granule polarization, but not degranulation (32) . Incompatibility of receptors and ligands between human and mouse cells may therefore explain the low cytotoxicity of mouse lymphoblasts by human NK cells and cannot be construed as global hyporesponsiveness in humanized mice because intact cytotoxicity against pig and K562 cells was seen for these human NK cells. Because global unresponsiveness was a manifestation of NK cell tolerance in rat-to-mouse chimeras, failure of human-to-mouse interactions may explain the failure to induce global hyporesponsiveness of human NK cells in the murine environment. Our results indicate that human NK cells developing in the presence of mixed xenogeneic chimerism may become hyporesponsive to pig cells, as demonstrated by the decreased cytotoxicity to pig cells in vitro of NK cells developing in mixed chimeras compared with those developing in control humanized mice. Thus, induction of mixed xenogeneic chimerism may be an approach to inducing human NK cell tolerance in addition to T and B cell tolerance to xenografts in humans, although additional approaches may be needed to improve its reliability.
In a rat-to-mouse bone marrow transplantation model, recipient mouse NK cells became tolerant to rat cells in association with global hyporesponsiveness (21) . In contrast, recipient NK cells were specifically tolerant to donor cells in mixed allogeneic chimeras (20) . We hypothesized that NK cells that receive unopposed activating signals from a xenogeneic cell population become anergic. Inhibitory receptors on murine NK cells are quite broad in their class I allorecognition (33) , and fully allogeneic class I molecules reduce NK-mediated marrow destruction compared to that of class I MHC-deficient cells (34, 35) . Xenogeneic MHC molecules tend not to interact with inhibitory NK cell receptors (36, 37) , whereas activating ligands often activate xenogeneic receptors (18, (38) (39) (40) . Thus, in rat-to-mouse mixed xenogeneic chimeras, most murine NK cells may undergo unopposed activation by xenogeneic rat hematopoietic cells, resulting in a state of "anergy" in all NK cells and global hyporesponsiveness (21) . This hypothesis is in keeping with the "disarming" model of NK cell tolerance (41) and with dominant tolerance induced by class I-deficient cells in mixed chimeras (42, 43) .
Many previously published studies demonstrated that inhibitory receptors on mature human NK cells were not able to recognize pig MHC molecules, whereas human NKactivating receptors can recognize their ligands expressed on pig cells (18, 19, (44) (45) (46) . If our observations in the rat-tomouse model apply to human NK cells, reduced human NK cell responses to pig cells would be expected to be associated with global hyporesponsiveness in pig/human mixed chimeric mice. However, our data showing partial or complete hyporesponsiveness of human NK cells to pig cells with normal reactivity to K562 cells in the majority of pig/human mixed chimeric mice suggest that some human NK cells receive inhibitory signals from the pig. Indeed, some studies suggested that certain unidentified ligands for human inhibitory KIRs are expressed by pig aortic endothelial cells, protecting them from human NK cell killing (47, 48) .
Human KIR polymorphism may explain the different impact of pig/human mixed chimerism on human NK cells observed in different experiments. The human KIR family contains 14 highly polymorphic genes that encode both inhibitory and activating receptors. Some genes have more than 50 alleles (49) . Each inhibitory KIR recognizes distinct subsets of HLA class I molecules, and some ligands are still unidentified (49) . SLA and HLA share considerable sequence homology (50, 51) . If there are indeed some pig SLA-human KIR interactions, outcomes would be expected to vary with the genotype of the particular pig-human pair being studied. Further studies are warranted to address this hypothesis.
We observed a lower percentage of CD56 dim CD16 bright and a higher percentage of CD56 bright CD16 dim human NK cell subsets in the BM of mixed chimeric compared with nonchimeric mice. Human peripheral blood CD56 dim CD16 bright NK cells are characterized by high cytotoxicity and low cytokine production; CD56 bright CD16 dim NK cells, in contrast, are characterized by low cytotoxicity and high cytokine production (52, 53) . Similar characteristics were recently reported for these NK cell subsets in human BM (28) . Thus, our observation that NK cells in BM of chimeric mice had decreased ability to produce IFN-c despite containing a higher percentage of CD56 bright CD16 dim NK cells compared with nonchimeric mice seems inconsistent with the published results. The discrepancy may reflect the type of stimulation used for cytokine measurement: cytokine stimulation was used in the published reports (52,53), whereas we used cellular stimulation. It is also possible that the higher percentage of CD56 bright CD16 dim human NK cells in the BM of chimeric mice reflects shedding of CD16 from NK cells upon encounter with pig cells, as reported for human NK cells encountering target cells (54) . Although metalloproteinase-17 (ADAM17)-mediated shedding of CD16 has been shown in human NK cells in response to cytokine and tumor stimulation in vitro (55), its role in tolerance induction of human NK cells is unknown. However, it is tempting to speculate that loss of the CD16 activation molecule could contribute to NK cell tolerance/loss of function in mixed chimeras.
Our data, to our knowledge, are the first to demonstrate that mixed xenogeneic hematopoietic chimerism leads to either specific hyporesponsiveness to pig cells or global hyporesponsiveness of human NK cells. Although these data support the use of this approach to xenograft tolerance, improvements are required to ensure tolerance of human NK cells with normal function. Whether induction of mixed xenogeneic chimerism could tolerize human NK cells in a preestablished immune system following conditioning and how preexisting NK cells affect pig bone marrow cell engraftment are remaining issues to address. Given the variable hyporesponsiveness of human NK cells to pig cells resulting from mixed xenogeneic chimerism in our study, more reliable solutions, such as the use of transgenic donor pigs expressing HLA class I molecules with broad NK inhibitory activities, such as HLA-E/human b2 microglobulin/leader peptide trimers (56), should be explored.
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Data S1: Supplemental methods. Figure 3 (A) were separated based on whether there was detectable pig chimerism in the spleen at the time of assay, and the ratio (9100%) of the maximum killing of pig lymphoblasts to that of K562 cells by NK cells of these two groups was compared. One mouse in the group with pig chimerism in the spleen did not have pig chimerism in bone marrow and liver; 2 mice in the group without pig chimerism in the spleen had pig chimerism in bone marrow, liver and blood. Error bars represent SEM. No significant difference was detected between these two groups. Table S1 : Global hyporesponsiveness of human NK cells from 3 mixed chimeric humanized mice. Three mice were excluded from the analysis shown in Figure 3 (A) because the maximum killing of K562 cells by NK cells of these chimeric mice was less than half that of the average maximum killing of K562 cells by NK cells of the nonchimeric mice in the same experiment, and NK cells from these mice were considered globally hyporesponsive. The cytotoxic activity of NK cells from these mice is shown.
